Gottlieb rebukes Nostrum's 300% price hike for generic antibiotic

A price hike of more than 300% by Nostrum Pharmaceuticals LLC (New Brunswick, N.J.) for a 65-year-old antibiotic met swift condemnation by FDA Commissioner Scott Gottlieb on Sept. 11.

Gottlieb said in a tweet that FDA will promote competition to nullify attempts by companies such as Nostrum "to take advantage of patients who need medicine."...